SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-049945
Filing Date
2014-07-02
Accepted
2014-07-02 16:05:42
Documents
3
Period of Report
2014-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-16448_18k.htm 8-K 37585
2 EX-4.1 a14-16448_1ex4d1.htm EX-4.1 133143
3 EX-10.1 a14-16448_1ex10d1.htm EX-10.1 568522
  Complete submission text file 0001104659-14-049945.txt   740652
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 14956459
SIC: 2834 Pharmaceutical Preparations